|
Myriad Genetics Inc.
(MYGN)
|
| |
| Sector: |
Healthcare |
| Industry: |
Diagnostic Substances |
| Stock Type: | Speculative Growth |
| Top Industry Grower: | QDEL |
MYGN was last updated 16 days 8 hours 7 minutes ago. Use MrStockQuickie's
Free Value Investor Tool to view this data in real time.
The Numbers
| metric | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| Return on Capital | -18.9% | -13.9% | -6.6% | -10.4% | -17.0% | -24.1% | -25.9% | -19.8% | -11.8% | 12.5% | 17.2% |
| Equity/Share | $2.68 | $3.88 | $6.35 | $5.60 | $6.54 | $6.42 | $4.52 | $6.94 | $8.30 | $9.25 | $10.15 |
| Earnings/Share | $-0.53 | $-0.43 | $-0.31 | $-0.59 | $-0.96 | $-1.49 | $-1.30 | $-1.05 | $-0.85 | $1.02 | $1.47 |
| FCF/Share | $-1.01 | $0.62 | $-0.41 | $-1.01 | $-2.18 | $-1.29 | $-1.00 | $-0.99 | $-0.91 | $0.00 | $0.00 |
| Sales/Share | $1.41 | $1.70 | $2.05 | $2.34 | $2.57 | $2.10 | $2.75 | $3.18 | $3.83 | $7.25 | $7.64 |
| Gross Margin | 87.9% | 88.3% | 83.6% | 80.1% | 80.5% | 75.7% | 75.3% | 75.8% | 80.4% | 90.3% | 90.3% |
The Growth Rates
ROIC
| 10 | 5 | 3 | 1 |
|---|
| -12% | -10% | -0% | 15% |
|
|
EPS
| <9> | <5> | <3> | 1 |
|---|
| 3% | 4% | 7% | 1,365% |
|
FCFPS
| 8 | 5 | 3 | 1 |
|---|
| -10% | 29% | 36% | 109% |
|
|
The Trends
long term trend
| ROIC | BVPS | EPS | FCFPS | SPS |
|---|
| 4% | 3% | 4% | 1% | 4% |
|
growth acceleration trend
| ROIC | BVPS | EPS | FCFPS | SPS |
|---|
| 9% | 0% | 409% | 37% | 6% |
|
Quick Financial Health
ebit/interest [on debt]
| MYGN | EQUITY_INDUSTRY | market |
|---|
| 14,741.00 | 5.30 | 58.10 |
|
cash/debt
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt |
| |
equity/debt
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt | Low Debt |
| |
assets/liabilities
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| 10.11 | 3.71 | 5.28 | 5.52 | 9.47 | 12.48 | 6.82 | 10.32 | 11.74 | 6.77 | 9.8 |
|
growth
| 10 | 5 | 3 | 1 |
|---|
| -0% | -5% | -2% | 45% |
|
The Ratios
PEG
| Entity | Current | Next Year (Current PE) | Next Year (Forward PE) | Five Year |
|---|
| MYGN | 1.12 | 0.82 | 0.69 | 1.49 | | Industry | 1.78 | 1.08 | 0.91 | 3.10 | | Market | 0.40 | 0.68 | 0.69 | 1.07 |
|
Valuations
| Entity | Price/Earnings | Price/Book | Price/Sales | Price/Cash Flow | Div. Yield (%) |
|---|
| MYGN | 44.0 | 6.3 | 8.7 | 27.9 | 0.0 | | Industry | 59.2 | 3.8 | 4.7 | 21.8 | 0.0 | | Market | 13.0 | 2.9 | 1.7 | 9.1 | 3.2 |
|
The Pricing Metrics
Growth Rates
| Zacks | Reuters | Thomson Fin. | BVPS | EPS | FCFPS | SPS |
|---|
| 25.0% | 25.0% | 25.0% | 12.5% | 5.9% | 12.1% | 24.7% | | Next Year's Growth Estimate | 53.7% | | Priced-In Growth | 25.0% | | Intrinsic Growth | 13.5% |
|
Mulitple History
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| -9.8 | -68.0 | -221.5 | -66.3 | -15.9 | -9.8 | -14.1 | -20.9 | -36.7 | 43.4 | | Front Loaded Estimate | -2.0 | | High Growth Estimate | 27.1 | | Five Year Avgerage | -7.6 |
|
Quality and Value
Quality (0-10)
| Inferior | Low | Below Avg. | Average | Above Avg. | High | Superior |
|---|
| | 5.0 | | | | | |
|
Valuations
| | PE | EPS | PRICE | VALUE/PRICE | MOS |
|---|
| Current Price | 44.0 | $1.48 | $65.11 | 1.000 | 0.0% | | Intrinsic Value | Indeterminable | | Price Adjusted for Industry | 44.0 | $1.48 | $65.11 | 1.000 | 0.0% | | Price Adjusted for Market | 11.4 | $1.48 | $16.85 | 0.259 | -286.3% | | EPS estimated FY08 Price | 43.7 | $1.42 | $62.19 | 0.955 | -4.7% | | EPS Quality (OIPS/E) | 1.62 | | Cash Quality (FCFPS/EPS) | 0.00 | | Short % of Float | 21.8% |
|
